Farallon Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-375,000
Closed -$10.9M 318
2021
Q1
$10.9M Buy
+375,000
New +$10.9M 0.05% 132